Pfizer CEO Joins Host of Executives at Covid-19 Vaccine Makers in Big Stock Sale

The timing this week of Albert Bourla's sale of about $5.6 million in company shares--on the same day it announced positive results from its Covid-19 vaccine--is drawing scrutiny from some investors